Navigation Links
Britain Undertakes Study into the Cause of Diseases

Britain plans to undertake the world’s largest study into the genetic and environmental causes of disease through the U.K. Biobank project.//

Its goal is to collect DNA samples from around 500,000 people between the ages of 40 and 69 and monitoring their health at the same time.

Participants in the project are expected to be found after letters targeting men and women in the appropriate age group are sent out, probably by the end of 2006. The recipients would then be assessed at one of the 35 centers in England, Ireland, Scotland and Wales. This process of recruitment is expected to last three or four years at least.

Eventually the $115 million Biobank is believed to be able to assist in finding cures for diseases like heart disease, cancer and diabetes. The effects of environment, genetics and lifestyle on disease are expected to be revealed through acess of the Biobank and its data.

U.K. Biobank`s principal investigator Professor Rory Collins said: 'For decades to come, the U.K. Biobank resource should provide researchers around the world with vital insights into some of the most distressing diseases of middle and old age.'

Professor Colin Blakemore, chief executive of Britain`s Medical Research Council, one of the investors in Biobank said, 'U.K. Biobank offers enormous potential to find out more about the complex links between our genes, the lives we lead and our health. Over the coming years, the data from this study will grow into a unique resource for future generations.'

Biobank however still does not have support from the medical community as a whole. Many are skeptical whether the scope of the project would ensure that the information held is accurate and honestly represented.
'"/>




Page: 1

Related medicine news :

1. Couples in Britain can have “designer” babis
2. Brain drain of dentists from Kerala to Britain
3. Doctor Training Undermined In Britain Due To Shortage Of Cadavers
4. Health Care Ties To Get Stronger Between India And Britain
5. Botched Abortions Trigger Concern Over Legal Ambiguity In Britain
6. Paid-For Sex Rates In Britain Has Increased Two Fold Over The Past 10 Years
7. Rise In Waterborne And Malaria Cases Anticipated In Britain
8. Britain Toddlers To Receive Flu-Jab In Addition To The 21 Shots
9. Prince Of Wales Is Alarmed By The Obesity Wave In Britain
10. New PPUD Syndrome Prevalent Among Indian Doctors In Britain
11. Britain Announces Third Transfusion Related Mad Cow Case
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... Y. (PRWEB) , ... February 27, 2017 , ... POUGHKEEPSIE, ... ILADS ) has disclosed that despite scientific studies, the Center for Disease Control ( ... chronic Lyme disease . Kenneth B. Liegner, M.D. has compiled into a single ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, a ... an upgrade to the company's Yelp listing. Bay Area residents struggling from thinning ... as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular Unit ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der ... , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... scheduling, and reporting for healthcare organizations. This comprehensive and customizable solution empowers ... process. StaffBridge technology improves staffing efficiency, maximizes resource allocation, collects critical reporting ...
(Date:2/25/2017)... ... February 25, 2017 , ... FCPX users now have the ability to ... Studios. With ProSharpen Color users have total control over sharpening amount, sharpening radius, threshold, ... With color spectrum tools users can visually see the color range effected with ease ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017  Interpace Diagnostics Group, ... provides clinically useful molecular diagnostic tests and pathology services, ... presented at the upcoming United States ... held March 4-10, 2017 in San Antonio, ... a review of data from the Company,s extensive experience ...
(Date:2/27/2017)... Fla. , Feb. 27, 2017 ... focused on developing cerebral embolic protection devices for ... the FDA,s Circulatory System Devices Panel that convened ... need for cerebral protection following transcatheter aortic valve ... by this FDA panel support the need for ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
Breaking Medicine Technology: